Industrial careers. Palle Høy Jakobsen Director Head, R&D Academic Fellowships Novo Nordisk A/S

Size: px
Start display at page:

Download "Industrial careers. Palle Høy Jakobsen Director Head, R&D Academic Fellowships Novo Nordisk A/S"

Transcription

1 Industrial careers Palle Høy Jakobsen Director Head, R&D Academic Fellowships Novo Nordisk A/S

2 A Mission Impossible? 10 Jan Career oppertunities. PRIVATE The pharmaceutical industry PUBLIC Universities

3 Novo Nordisk at a glance Introduction to the company Novo Nordisk is a global healthcare company with 90 years of innovation and leadership within: diabetes care insulin injection devices Thanks to dedicated research into proteins, Novo Nordisk also holds leading positions within: haemostasis management growth hormone therapy hormone replacement therapy

4

5 Protein engineering and formulation Protein drug delivery Large-scale biologics manufacturing Global commercial infrastructure A Mission Impossible? 10 Jan Novo Nordisk at a glance Therapeutic area Compounds and capabilities Strategic focus Diabetes Insulin and GLP-1 Expand leadership Obesity GLP-1 Establish presence Haemophilia Coagulation factors Expand portfolio Growth disorders Human growth hormone Achieve leadership Novo Nordisk Way

6 A Mission Impossible? 10 Jan The R&D Process (drugs & devices) Idea Pre-project Research Clinical Manufacturing Pre-clinical tests Clinical trials Phases 1-3 Product registration Preparing for launch Reaching the market Phase 4 trials

7 A Mission Impossible? 10 Jan Over 4,000 Novo Nordisk employees contribute to R&D value chain External collaborations Quality (Corporate Relations) Diabetes Research Unit (950) Device R&D (311) Biopharm Research Unit (563) External collaborations CMC Supply (1,057) CMC: Chemistry, Manufacturing, Control Global Development (893) Haemophilia R&D Portfolio (33) Regulatory Affairs (368) New Product Planning (Operations) R&D staffs (Strategic R&D) : 38 Regional CMR* offices staff: 973 Last updated: Q Source: People data *Clinical Medical Regulatory

8 Global R&D A Mission Impossible? 10 Jan Denmark Seattle Princeton Beijing Bangalore CMR* regions: *CMR: Clinical Medical Regulatory North America (Princeton, NJ) Europe (Zürich) International Operations (Zürich) Japan/Korea (Tokyo) China (Beijing) Research & Development Denmark Beijing, China Seattle, WA, USA Princeton, NJ, USA Bangalore, India

9 A Mission Impossible? 10 Jan 2013 Slide no 9 Novo Nordisk R&D S T R Programme Science Talent Attraction & Recruitment Novo Scholarships Grant to write master thesis at Danish universities and Lund university Grant to Medical Research Year at Danish universities Co-funded PhD. fellowships Industrial PhD PhD Schools at Danish universities STAR International PhDs (foreign host university) PostDocs STAR Post Docs, For STAR PhDs and exceptionally qualified scientists incl. medical doctors

10 STAR PostDoc Fellows 2013 Active and completed June 2013 Sigma Aldrich (SAFC) Loyola Toronto McGill Nottingham Vrije Linköping Karolinska Institutet Washington Manchester Uppsala Fudan Dublin Lund Stanford Kings College Setsunan, Osaka, Japan Santiago de Compostela San Francisco Justus-Liebig The Hebrew -Hadassah Tokyo Berkley Geneva Martin Luther Burnham Institut Medical Research Chapel Hill Princeton Harvard Consiglio Nazionale delle Ricerche Institute for Biomedicine and Health Science R&D locations Clinical Medical Regulatory Offices

11 Diversity fosters innovation A Mission Impossible? 10 Jan

12 STAR fellowship postgraduate training 2013

13 STAR Symposium activities

14 Novo Nordisk STAR fellows Professional Qualifications Strong competences from active research environments International experience and networks Good publications (and PhD thesis) and/or patent applications Skills in new technologies High personal ambitions

15 Fellowship Programmes Talent Attraction Knowledge Transfer Long term Relations Support of Education System

16 Career paths in Novo Nordisk A Mission Impossible? 10 Jan

17 How can I develop? A Mission Impossible? 10 Jan

18 More information at novonordisk.com/careers

19 A Mission Impossible? 10 Jan Conclusions [ ] you can't connect the dots looking forward; you can only connect them looking backwards. So you have to trust that the dots will somehow connect in your future. Steve Jobs, Commencement address Stanford, June 2005 But you can increase the odds Work hard Diversify Follow your passion

11. December 2017 Marianne Birkeland Kjær

11. December 2017 Marianne Birkeland Kjær 1 11. December 2017 Marianne Birkeland Kjær Presentation title Date 2 Agenda My Background Novo Nordisk Overview PhD and PostDoc opportunities How to apply for regular positions Novo Nordisk standard recruitment

More information

novo nordisk R&D AT A GLANCE

novo nordisk R&D AT A GLANCE novo nordisk R&D AT A GLANCE LIU WEI & THOMAS JUNKER ALSTED Liu is a special technician and Thomas is an international postdoc in Research & Development in Novo Nordisk, Denmark PASSIONATE ABOUT PROTEINS

More information

The value of integrated reporting

The value of integrated reporting The value of integrated reporting Jesper Lindhardt Director Triple Bottom Line Strategy & Performance Management Novo Nordisk at a glance Key facts A focused pharmaceutical company with leading positions

More information

Our future workforce. Flemming Dahl, Senior Vice President and Head of Quality, Novo Nordisk

Our future workforce. Flemming Dahl, Senior Vice President and Head of Quality, Novo Nordisk Our future workforce Flemming Dahl, Senior Vice President and Head of Quality, Novo Nordisk ISPE Nordic 17. Nov. 2016 2 Who am I? Head of Quality in Novo Nordisk 48 years Danish Married 5 Children [7-19]

More information

2016 EFPIA Data Collection and Reporting Experience - Novo Nordisk A/S learnings

2016 EFPIA Data Collection and Reporting Experience - Novo Nordisk A/S learnings CBI Global Transparency Reporting Congress, London 4 April 2017 1 2016 EFPIA Data Collection and Reporting Experience - Novo Nordisk A/S learnings London 4-Apr-2017 CBI Global Transparency Reporting Congress,

More information

Slide 1. Welcome and introduction. Lars Rebien Sørensen President & CEO

Slide 1. Welcome and introduction. Lars Rebien Sørensen President & CEO Slide 1 Lars Rebien Sørensen President & CEO Slide 2 Capital Markets Day 2015 Slide 3 Forward-looking statements Novo Nordisk s reports filed with or furnished to the US Securities and Exchange Commission

More information

Metabolism and diabetes

Metabolism and diabetes Metabolism and diabetes Research strengths of Greater Copenhagen with investment prospects LauritzenConsulting Greater Copenhagen is home to one of the leading research clusters in the world in metabolism

More information

Slide 1. Investor presentation. Copenhagen 1 November 2018

Slide 1. Investor presentation. Copenhagen 1 November 2018 Slide 1 Investor presentation Copenhagen 1 November 2018 Manato Shirley Ohara, Adelia Stewart diagnosed has type with 2 diabetes type 1 diabetes Kanagawa, New Orleans, Japan Louisiana, US Slide 2 Highlights

More information

Slide 1. Welcome and strategy update. Lars Fruergaard Jørgensen President and CEO

Slide 1. Welcome and strategy update. Lars Fruergaard Jørgensen President and CEO Slide 1 Lars Fruergaard Jørgensen President and CEO Slide 2 Forward-looking statements Novo Nordisk s reports filed with or furnished to the US Securities and Exchange Commission (SEC), including the company

More information

Slide 1. Investor presentation. Meet the Management London, 9 August 2018

Slide 1. Investor presentation. Meet the Management London, 9 August 2018 Slide 1 Investor presentation Meet the Management London, 9 August 2018 Manato diagnosed with type 1 diabetes Shirley Ohara, Adelia Stewart has type 2 diabetes Kanagawa, Japan New Orleans, Louisiana, US

More information

Slide 1. International Operations update. Mike Doustdar EVP International Operations. YASMIN FIEDLER, Germany Yasmin has type 1 diabetes

Slide 1. International Operations update. Mike Doustdar EVP International Operations. YASMIN FIEDLER, Germany Yasmin has type 1 diabetes Slide 1 International Operations update Mike Doustdar EVP International Operations YASMIN FIEDLER, Germany Yasmin has type 1 diabetes Slide 2 Forward-looking statements Novo Nordisk s reports filed with

More information

Slide 1. Financial update and closing remarks. Jesper Brandgaard EVP and CFO. RAFAEL DE JESÚS FLORES, Mexico Rafael has haemophilia A

Slide 1. Financial update and closing remarks. Jesper Brandgaard EVP and CFO. RAFAEL DE JESÚS FLORES, Mexico Rafael has haemophilia A Slide 1 Financial update and closing remarks Jesper Brandgaard EVP and CFO RAFAEL DE JESÚS FLORES, Mexico Rafael has haemophilia A Slide 2 Forward-looking statements Novo Nordisk s reports filed with or

More information

STRATEGIC PLAN

STRATEGIC PLAN STRATEGIC PLAN 2016 2020 Promoting and supporting excellence in research www.immunology.org BSI STRATEGY 2016 2020 EXECUTIVE SUMMARY OUR MISSION Our mission is to promote excellence in immunological research,

More information

World Premier International Research Center (WPI) Initiative General Comments on FY2007 WPI Project Progress by Program Committee

World Premier International Research Center (WPI) Initiative General Comments on FY2007 WPI Project Progress by Program Committee World Premier International Research Center (WPI) Initiative General Comments on FY2007 WPI Project Progress by Program Committee WPI Research Centers In October 2007, the Ministry of Education, Culture,

More information

Melanoma. Research Alliance. Fast-Forwarding a Cure for Deadly Skin Cancer

Melanoma. Research Alliance. Fast-Forwarding a Cure for Deadly Skin Cancer . Melanoma Research Alliance Fast-Forwarding a Cure for Deadly Skin Cancer Vision Targeting an urgent problem. Melanoma often starts out small, misleadingly insignificant a change in a mole, a mark on

More information

Metrology in pharmaceutical production

Metrology in pharmaceutical production Metrology in pharmaceutical production 22/05/2013 1 Metrology in pharmaceutical production Metrologidag 2013 Lorenzo Carli, Ph.D. lzcl@novonordisk.com Contributions from: Jan Lasson Andreasen (R&D) Kirsten

More information

1 November, 2013 or earlier

1 November, 2013 or earlier Job Description JOB TITLE REPORTING RELATIONSHIPS COMPANY START DATE Research Fellow/Senior Research Fellow Deputy Director, The George Institute India Programme Head, Global Surgery and Disability Research,

More information

NEWSLETTER June Summer greetings from Follicum

NEWSLETTER June Summer greetings from Follicum NEWSLETTER June 2018 Follicum hopes that this newsletter reaches as many of the company's owners and stakeholders as possible. If you wish to follow our continued development, please register your e-mail

More information

International Operations overview and strategy. Maziar Mike Doustdar EVP International Operations. Slide 1

International Operations overview and strategy. Maziar Mike Doustdar EVP International Operations. Slide 1 Slide 1 International Operations overview and strategy Maziar Mike Doustdar EVP International Operations KUALA LUMPUR Home of International Operations Business Area Southeast Asia Slide 2 Forward-looking

More information

Forensic Graduates Require Hard Science, Soft Skills

Forensic Graduates Require Hard Science, Soft Skills Forensic Graduates Require Hard Science, Soft Skills Forensic Graduates Require Hard Science, Soft Skills By Adam Denmark, AIA, LEED AP BD+C and Steve Hackman, AIA, LEED AP The forensic field is attracting

More information

Chronic illness is a growing market for Novo Nordisk

Chronic illness is a growing market for Novo Nordisk Chronic illness is a growing market for Novo Nordisk Aslam Dalvi - Associate Portfolio Manager Denmark-based global healthcare company Novo Nordisk traces its origins to the first pioneers in insulin production

More information

Academic collaboration: Sweden Japan

Academic collaboration: Sweden Japan Academic collaboration: Sweden Japan STINT The Swedish Foundation for International Cooperation in Research and Higher Education CR 2018:01 ??, 2018 Introduction This report aims to provide an overview

More information

National Rural Health Association: Internship Opportunities

National Rural Health Association: Internship Opportunities National Rural Health Association: Internship Opportunities Rural Health Forum Shepherd University April 28, 2017 Amy Elizondo, MPH Vice President, Program Services National Rural Health Association Texas

More information

Task Force Members: Mandy Lauw, Chairman Geoff Barnes, Immediate Past Chairman

Task Force Members: Mandy Lauw, Chairman Geoff Barnes, Immediate Past Chairman Task Force Members: Mandy Lauw, Chairman Mandy Lauw (30, The Netherlands) is a Research Fellow at the Departments of Vascular Medicine and Hematology, Academic Medical Center, Amsterdam, The Netherlands,

More information

Slide 1. Investor presentation. London 5 February 2019

Slide 1. Investor presentation. London 5 February 2019 Slide Investor presentation London 5 February 209 Slide 2 Forward-looking statements Novo Nordisk s reports filed with or furnished to the US Securities and Exchange Commission (SEC), including this presentation

More information

Strategy Department of Psychology University of Copenhagen

Strategy Department of Psychology University of Copenhagen Strategy 2018-2021 Department of Psychology University of Copenhagen Copenhagen / May, 2018 Foreword This strategy for the Department of Psychology spans the years 2018-2021. In this period, we aim to

More information

Schulich Dentistry STRATEGIC PLAN Schulich School of Medicine & Dentistry, Western University

Schulich Dentistry STRATEGIC PLAN Schulich School of Medicine & Dentistry, Western University Schulich Dentistry STRATEGIC PLAN 2016-2026 Schulich School of Medicine & Dentistry, Western University INTRODUCTION INTRODUCTION Schulich Dentistry stands at the juncture of past, including students,

More information

Championing patients every step of the way

Championing patients every step of the way Championing patients every step of the way The majority of people living with a rare disease have no treatment for their condition. At Shire, we have long believed we have a unique opportunity to champion

More information

Partnering for Growth

Partnering for Growth Partnering for Growth JP Morgan Healthcare Conference Simon Lowth, Chief Financial Officer, AstraZeneca 9 January 2013 Partnering for Growth Agenda Our platforms for growth Partnering strategy and capabilities

More information

Who we are. We envision a world where high quality eye health and vision care is accessible to all people.

Who we are. We envision a world where high quality eye health and vision care is accessible to all people. Who we are The World Council of Optometry (WCO) is an international optometric association founded in 1927. The WCO represents over 200,000 optometrists in more than 60 countries, through almost 300 Country,

More information

Boehringer Ingelheim BioXcellence. Producing Value. Global Contract Manufacturing Excellence

Boehringer Ingelheim BioXcellence. Producing Value. Global Contract Manufacturing Excellence Boehringer Ingelheim BioXcellence Producing Value Global Contract Manufacturing Excellence Your World Class Contract Manufacturer Boehringer Ingelheim BioXcellence Producing Value Boehringer Ingelheim

More information

Singapore s Progress on GLP and MAD

Singapore s Progress on GLP and MAD 2010/SOM1/CD/WKSP/025 Agenda Item: Afternoon Session I Singapore s Progress on GLP and MAD Submitted by: Singapore Case Study Workshop on the Chemicals Sector - From Principles to Practice Hiroshima, Japan

More information

ALL LIVES HAVE EQUAL VALUE

ALL LIVES HAVE EQUAL VALUE ALL LIVES HAVE EQUAL VALUE Global Health Product Development Challenges and Opportunities IQ Symposium, Oct 5, 2016 Niya Bowers Senior Program Officer, CMC, Integrated Development 2015 Bill & Melinda Gates

More information

Shareholder Presentation Annual Meeting 2018

Shareholder Presentation Annual Meeting 2018 Shareholder Presentation Annual Meeting 2018 FY 18 HIGHLIGHTS Strong sales growth of 2 nd Gen TruScreen to China commenced during 4 th quarter. (50% of the year s sales were generated in the fourth quarter)

More information

STRATEGIC PLAN

STRATEGIC PLAN STRATEGIC PLAN 2019-2028 3 EXECUTIVE SUMMARY Health at the center Good health changes everything. With good health, children can learn, parents can provide and neighbors can work together to build, and

More information

Agenda 2030: One Nation Labour s Plan for science Response from Alzheimer s Research UK

Agenda 2030: One Nation Labour s Plan for science Response from Alzheimer s Research UK Agenda 2030: One Nation Labour s Plan for science Response from Alzheimer s Research UK 1. Introduction 1.1. Alzheimer s Research UK is the UK s leading dementia research charity. As research experts,

More information

Digestive & Metabolic Diseases

Digestive & Metabolic Diseases 4 th World Congress on Digestive & Metabolic Diseases October 29-30, 2018 San Francisco, California, USA Invitation Dear Attendees, We are glad to announce the 4 th World Congress on Digestive & Metabolic

More information

Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC

Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives Oncology Therapeutic Area Janssen Research & Development, LLC The patients are waiting. Dr. Paul Janssen To Our Potential

More information

A Strategic Roadmap for the PICARD Programme in 2020

A Strategic Roadmap for the PICARD Programme in 2020 A Strategic Roadmap for the PICARD Programme in 2020 DRAFT 1. Background Since the launch of the WCO Partnership In Customs Academic Research and Development (PICARD) Programme in 2006, its two objectives

More information

The corporate responsibility for health in society

The corporate responsibility for health in society The corporate responsibility for health in society 20 May 2010 The corporate responsibility for health in society Lars Rebien Sørensen CEO & President Novo Nordisk A/S The corporate responsibility for

More information

Oral semaglutide and production expansion. Henrik Wulff EVP Product Supply. Peter Kristensen SVP Global Development

Oral semaglutide and production expansion. Henrik Wulff EVP Product Supply. Peter Kristensen SVP Global Development YASMIN FIEDLER Germany Yasmin has type 1 diabetes Slide 1 Oral semaglutide and production expansion Henrik Wulff EVP Product Supply Peter Kristensen SVP Global Development Slide 2 Forward-looking statements

More information

Program Officer, Sub-Saharan Africa: Population & Reproductive Health

Program Officer, Sub-Saharan Africa: Population & Reproductive Health Program Officer, Sub-Saharan Africa: Population & Reproductive Health Location: Los Altos, California Search conducted by: waldronhr.com The Organization The David and Lucile Packard Foundation is a family

More information

DEVELOPMENT OF PLATFORM INJECTION DEVICES ADDRESSING HUMAN FACTORS AT AN EARLY STAGE FOR DIFFERENT USER GROUPS

DEVELOPMENT OF PLATFORM INJECTION DEVICES ADDRESSING HUMAN FACTORS AT AN EARLY STAGE FOR DIFFERENT USER GROUPS DEVELOPMENT OF PLATFORM INJECTION DEVICES ADDRESSING HUMAN FACTORS AT AN EARLY STAGE FOR DIFFERENT USER GROUPS In this article Orfeo Niedermann, Business Development Director, and Jakob Lange, PhD, Account

More information

TREAT U is a spin-off from the University of Coimbra, founded in January 2010, and headquartered in Coimbra, Portugal.

TREAT U is a spin-off from the University of Coimbra, founded in January 2010, and headquartered in Coimbra, Portugal. TREAT U is a spin-off from the University of Coimbra, founded in January 2010, and headquartered in Coimbra, Portugal. MISSION & VISION Our mission is to develop more effective strategies and safer products

More information

OUR STRATEGIC PLAN

OUR STRATEGIC PLAN OUR STRATEGIC PLAN 2017-2021 Changing lives through innovation and excellence IHMRI ABOUT US We re front line innovators: As the only independent medical research institute (MRI) in the Illawarra region

More information

Collaboration between Ajinomoto and ASEAN countries based on umami research activities

Collaboration between Ajinomoto and ASEAN countries based on umami research activities 40 th Year of ASEAN-Japan Friendship and cooperation Symposium on Human Resource Development In Food-related Area through Partnership with ASEAN Universities January 21 st 2014 Indonesia Jakarta Collaboration

More information

Making Life Better COMMUNITY BENEFIT REPORT

Making Life Better COMMUNITY BENEFIT REPORT Making Life Better COMMUNITY BENEFIT REPORT Satellite Healthcare s dedication to patient care extends beyond the doors of our centers. As a company and as individuals, Satellite teams donate money, time,

More information

Boston Scientific is advancing...

Boston Scientific is advancing... Boston Scientific is advancing... Our mission Our values Boston Scientific is dedicated to transforming lives through innovative Caring Meaningful Innovation High Performance medical solutions that improve

More information

DIABETES CARE DEVICES MARKET IN BRAZIL, RUSSIA, INDIA & CHINA (BRIC)

DIABETES CARE DEVICES MARKET IN BRAZIL, RUSSIA, INDIA & CHINA (BRIC) DIABETES CARE DEVICES MARKET IN BRAZIL, RUSSIA, INDIA & CHINA (BRIC) R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p

More information

CREATING A DOHAD GLOBAL NETWORK: USING OTHER NETWORKS AS A MODEL

CREATING A DOHAD GLOBAL NETWORK: USING OTHER NETWORKS AS A MODEL CREATING A DOHAD GLOBAL NETWORK: USING OTHER NETWORKS AS A MODEL William A. Suk, Ph.D., M.P.H. Director, Superfund Research Program Chief, Hazardous Substances Research Branch Division of Extramural Research

More information

Brain research supported by the European Union

Brain research supported by the European Union Brain research supported by the European Union Lara Passante, PhD Health Directorate Directorate-General for Research & European Commission FENS Featured Regional Meeting 11-14 Septembre 2013 Prague Neuroscience:

More information

Program Priorities 2018

Program Priorities 2018 Program Priorities 2018 Blank Page 2 CONTENTS: About CPRIT Program Priorities Project...Page 5 Process to Develop Program Priorities...Page 6 Scope of Program Priorities Project...Page 6 CPRIT s Long-Term

More information

Managing & Aligning Lists of Chemicals of High Concern

Managing & Aligning Lists of Chemicals of High Concern Managing & Aligning Lists of Chemicals of High Concern Ivan Welvaert Director, Global Product Stewardship Office of Global Sustainability December, 2017 Boston, US 2017 BD. BD, the BD Logo and all other

More information

Type 1 Diabetes (T1D) Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research

Type 1 Diabetes (T1D) Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research Type 1 Diabetes (T1D) Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research "Type 1 diabetes market size was valued at USD 25.52 billion in 2016 and is expected to exhibit rewarding

More information

Jennifer E. Mason (803)

Jennifer E. Mason   (803) Jennifer E. Mason http://people.engr.ncsu.edu/jemason2/ jemason2@ncsu.edu, (803) 608-0727 Research Interests Stochastic dynamic programming and stochastic models Applications in health care delivery and

More information

Establishing LCA in the Healthcare Sector

Establishing LCA in the Healthcare Sector Establishing LCA in the Healthcare Sector Nanja Hedal Kløverpris Abstract Novo Nordisk has used Life Cycle Assessment (LCA) for many years and a few years ago the company took a major step forward and

More information

Introducing Patheon in Milton Park

Introducing Patheon in Milton Park Introducing Patheon in Milton Park SCOTLAND ABERDEEN GLASGOW EDINBURGH NORTHEN IRELAND BELFAST LEEDS DUBLIN MANCHESTER LIVERPOOL WALES SHEFFIELD ENGLAND CAMBRIDGE OXFORD CARDIFF BRISTOL MILTON PARK LONDON

More information

Strategic Plan

Strategic Plan Strategic Plan 2013-2018 Strategic Plan 2013-2018 Contents The Challenges of an Aging Population.. Baycrest: fulfilling a legacy of commitment and accomplishment Looking Ahead: dedicated to serve our local

More information

Diabetes Fonds Fellowships

Diabetes Fonds Fellowships Diabetes Fonds Fellowships Background Diabetes is the most common chronic disease in the Netherlands and a growing burden on society. Despite the large number of people affected, diabetes remains an underestimated

More information

Parkinson s Institute and Clinical Center Appoints Anthony Santiago, M.D., Neurologist and Movement Disorders Specialist as Chief Medical Officer

Parkinson s Institute and Clinical Center Appoints Anthony Santiago, M.D., Neurologist and Movement Disorders Specialist as Chief Medical Officer Press Release For Immediate Release October 30, 2017 Contact: Chris Di Salvo Mobile: (408) 506-0455 E-mail: profeff@aol.com Parkinson s Institute and Clinical Center Appoints Anthony Santiago, M.D., Neurologist

More information

What Services do Registered Dietitian Nutritionists (RDN) Provide?

What Services do Registered Dietitian Nutritionists (RDN) Provide? What Services do Registered Dietitian Nutritionists (RDN) Provide? The majority of Registered Dietitian Nutritionists (RDN) s work in the treatment and prevention of disease (administering medical nutrition

More information

Who we are. We envision a world where high quality eye health and vision care is accessible to all people.

Who we are. We envision a world where high quality eye health and vision care is accessible to all people. Who we are The World Council of Optometry (WCO) is an international optometric association founded in 1927. The WCO represents over 200,000 optometrists in more than 60 countries, through almost 300 Country,

More information

PPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM

PPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM HEMATOLOGY ONCOLOGY PPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM COMMITTED TO ADVANCING DRUG DEVELOPMENT IN ONCOLOGY $ MARKETPLACE COMPLEXITIES increasingly competitive marketplace and rising cost pressures

More information

Table of Contents. 1. About Solvay Solvay at a Glance Group Portfolio Transforming Solvay Solvay s Portfolio Upgrade 7

Table of Contents. 1. About Solvay Solvay at a Glance Group Portfolio Transforming Solvay Solvay s Portfolio Upgrade 7 Solvay Media Kit Table of Contents 1. About Solvay 3 1.1. Solvay at a Glance 4 1.2. Group Portfolio 5 2. Transforming Solvay 6 2.1. Solvay s Portfolio Upgrade 7 3. Organizing for the Future 9 3.1. Why

More information

GN Store Nord Goldman Sachs European Medtech and Healthcare Services Conference. CEO GN ReSound, Mike van der Wallen September 3, 2008

GN Store Nord Goldman Sachs European Medtech and Healthcare Services Conference. CEO GN ReSound, Mike van der Wallen September 3, 2008 GN Store Nord Goldman Sachs European Medtech and Healthcare Services Conference CEO GN ReSound, Mike van der Wallen September 3, 2008 GN Store Nord A/S GN GN Store Store Nord Nord Listed Listed company

More information

Position Profile Chief Executive Officer Feeding America San Diego San Diego, CA

Position Profile Chief Executive Officer Feeding America San Diego San Diego, CA Position Profile Chief Executive Officer Feeding America San Diego San Diego, CA Feeding America San Diego is seeking an experienced and inspirational Chief Executive Officer to lead this impactful and

More information

CANCER RESEARCH UK SPONSORSHIP OPPORTUNITIES

CANCER RESEARCH UK SPONSORSHIP OPPORTUNITIES CANCER RESEARCH UK SPONSORSHIP OPPORTUNITIES Cancers of Unmet Need: Our Ambition Over the last 40 years, improvements in prevention, detection and treatment have revolutionised cancer medicine and survival

More information

BARDA s Division of Chemical, Biological, Radiological and Nuclear Medical Countermeasures

BARDA s Division of Chemical, Biological, Radiological and Nuclear Medical Countermeasures BARDA s Division of Chemical, Biological, Radiological and Nuclear Medical Countermeasures Joe Larsen, Ph.D. Director (Acting) BARDA Division of CBRN Medical Countermeasures January 2018 ASPR: Saving Lives

More information

Creating Shared Value and meeting our commitments

Creating Shared Value and meeting our commitments Creating Shared Value and meeting our commitments Swiss Sustainability Leaders SRI Conference Zug, Janet Voûte Vice President, Global Head of Public Affairs Nestlé Nestlé at a glance Started in 1866 as

More information

ESMO FELLOWSHIP PROGRAMME & LEADERS GENERATION PROGRAMME

ESMO FELLOWSHIP PROGRAMME & LEADERS GENERATION PROGRAMME ESMO FELLOWSHIP PROGRAMME & LEADERS GENERATION PROGRAMME Christoph Zielinski Chair of the ESMO Fellowship & Award Committee esmo.org ESMO FELLOWSHIP PROGRAMME Exclusive to ESMO members under 40 years old

More information

Symposium Program. #CLEARsymposium17. lean-healthcare-research-symposium/

Symposium Program. #CLEARsymposium17.   lean-healthcare-research-symposium/ Symposium Program #CLEARsymposium17 www.clear.berkeley.edu/events/ lean-healthcare-research-symposium/ THANK YOU TO OUR SPONSORS WELCOME LETTER On behalf of the organizing committee we are delighted to

More information

Opportunity Knocks: FDA/CDRH Medical Device Fellowship and External Expertise

Opportunity Knocks: FDA/CDRH Medical Device Fellowship and External Expertise Opportunity Knocks: FDA/CDRH Medical Device Fellowship and External Expertise Nancy J. Pluhowski Director, Office of the Center Director Center for Devices and Radiological Health (CDRH), FDA Stanford

More information

Integrating Project Management Standards within Business Technology Management (BTM)

Integrating Project Management Standards within Business Technology Management (BTM) Integrating Project Management Standards within Business Technology Management (BTM) gagnontech.org btm-forum.org stephane.gagnon@uqo.ca Prof. Université du Québec, Canada Objectives 1. Meet PM 2 community,

More information

The Dual Hormonal Artificial Pancreas in Diabetes Management. Medical Innovation Day Challenge

The Dual Hormonal Artificial Pancreas in Diabetes Management. Medical Innovation Day Challenge The Dual Hormonal Artificial Pancreas in Diabetes Management Medical Innovation Day Challenge 1 Background for the challenge A paradigm shift in treating diabetes Zealand Pharma is a Danish biotech company

More information

New Developments and Regulatory Issues SLEEP AND CIRCADIAN RESEARCH. October 11-12, 2018 AGENDA

New Developments and Regulatory Issues SLEEP AND CIRCADIAN RESEARCH. October 11-12, 2018 AGENDA AGENDA SLEEP AND CIRCADIAN RESEARCH New Developments and Regulatory Issues October 11-12, 2018 Hilton Alexandria Mark Hotel 5000 Seminary Road, Alexandria, VA 22311 The Sleep Research Society would like

More information

Towards a Sustainable Global Infrastructure for Medical Countermeasures

Towards a Sustainable Global Infrastructure for Medical Countermeasures Towards a Sustainable Global Infrastructure for Medical Countermeasures Institute of Medicine The Public Health Emergency Medical Countermeasures Enterprise: Innovative Strategies to Enhance Products from

More information

Sign Linguistics Training: An Alternative Approach to Deaf Education

Sign Linguistics Training: An Alternative Approach to Deaf Education Sign Linguistics Training: An Alternative Approach to Deaf Education Gladys Tang Director, Centre for Sign Linguistics and Deaf Studies (CSLDS) Chairperson, Department of Linguistics and Modern Languages

More information

Using the Mozambique National Quality Policy to Encourage Biomedical Research, Innovation, & Infrastructure Investment

Using the Mozambique National Quality Policy to Encourage Biomedical Research, Innovation, & Infrastructure Investment Using the Mozambique National Quality Policy to Encourage Biomedical Research, Innovation, & Infrastructure Investment Rachael Eckles, JD/MA Director, Regulatory Policy Bristol-Myers Squibb August 10,

More information

Medpace, a pioneer in the development of therapeutics to treat metabolic disorders, is your first stop for compound development in lipid studies.

Medpace, a pioneer in the development of therapeutics to treat metabolic disorders, is your first stop for compound development in lipid studies. THE POWER OFx MEDPACE ADVANTAGE FOR LIPID STUDIES Experts. Experience. Execution. Medpace, a pioneer in the development of therapeutics to treat metabolic disorders, is your first stop for compound development

More information

Slide 1. R&D strategy. Mads Krogsgaard Thomsen EVP and Chief Science Officer. ZIHAO LI AND HIS MOTHER BING HAN, China Zihao has haemophilia A

Slide 1. R&D strategy. Mads Krogsgaard Thomsen EVP and Chief Science Officer. ZIHAO LI AND HIS MOTHER BING HAN, China Zihao has haemophilia A Slide 1 R&D strategy Mads Krogsgaard Thomsen EVP and Chief Science Officer ZIHAO LI AND HIS MOTHER BING HAN, China Zihao has haemophilia A R&D strategy Slide 2 Forward-looking statements Novo Nordisk s

More information

The more question you ask the more different answers you will get

The more question you ask the more different answers you will get The more question you ask the more different answers you will get Experience and lessons learned in China Ulrike Bauer Cicor Innovation Insights Symposium Kloten, September 27, 2016 Agenda Introduction

More information

R&D Status in Romania

R&D Status in Romania R&D Status in Romania Romania Economy is the second largest country in the Central and Eastern Europe (after Poland); it has a population of 22 million people; it benefits from a strategic geographic position;

More information

Adding Value to the NHS, Health and Care, through Research Management, Support & Leadership

Adding Value to the NHS, Health and Care, through Research Management, Support & Leadership Invitation to Comment This new draft strategy has been developed to ensure that the Forum continues to thrive, that we meet the needs of the community over the next five years, and that by acting together

More information

Scottish Clinical Leadership Fellowship About the SCLF

Scottish Clinical Leadership Fellowship About the SCLF Scottish Clinical Leadership Fellowship About the SCLF Scottish Clinical Leadership Fellowship This guide introduces the Scottish Clinical Leadership Fellowship (SCLF) for doctors and dentists in training,

More information

Orthopedics/Orthopedic Surgery CV #6002

Orthopedics/Orthopedic Surgery CV #6002 Orthopedics/Orthopedic Surgery CV #6002 Publications and presentations available upon request. Contact Dora, dmancias@expertwitnessdoctors.com. EDUCATION: Undergraduate Cornell University, College of Arts

More information

AAENP 2017 YEAR IN REVIEW

AAENP 2017 YEAR IN REVIEW AAENP 2017 YEAR IN REVIEW PROGRESS, CHAOS AND CHANGE Birth and Trajectory of a Disruptive Organization DISCLOSURES I have nothing to disclose TRENDS IN EMERGENCY CARE 130,400,000 annual ED visits (NHAMCS,

More information

FDA Approves New Novo Nordisk Treatment for Patients with Hemophilia

FDA Approves New Novo Nordisk Treatment for Patients with Hemophilia FDA Approves New Novo Nordisk Treatment for Patients with Hemophilia PLAINSBORO, N.J., May 31, 2017 Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics

More information

FRANKFURT SITE TOUR 2017

FRANKFURT SITE TOUR 2017 FRANKFURT SITE TOUR 2017 MEDIA INFORMATION FRANKFURT SITE TOUR 2017 CONTENTS FRANKFURT INSULIN CITY... 4 5 DIABETES BACKGROUNDER... 6 DIABETES STATISTICS... 7 DIABETES MEDICINES... 8 IMAGE BANK... 9 NOTES...

More information

2015 Net Impact Conference

2015 Net Impact Conference 2015 Net Impact Conference November 5-7 Seattle, WA Mobilizing Next Generation Leaders to Drive Positive Impact 2015 Net Impact Conference Net Impact Net Impact empowers a new generation of leaders to

More information

THE CARDIFF COMMITMENT TO YOUTH ENGAGEMENT AND PROGRESSION: REPORT OF DIRECTOR OF EDUCATION & LIFELONG LEARNING

THE CARDIFF COMMITMENT TO YOUTH ENGAGEMENT AND PROGRESSION: REPORT OF DIRECTOR OF EDUCATION & LIFELONG LEARNING CITY OF CARDIFF COUNCIL CYNGOR DINAS CAERDYDD EXECUTIVE PUBLIC SERVICES BOARD: 10 TH MARCH 2017 THE CARDIFF COMMITMENT TO YOUTH ENGAGEMENT AND PROGRESSION: REPORT OF DIRECTOR OF EDUCATION & LIFELONG LEARNING

More information

Acquisition of Novartis Influenza Vaccines Business. 27 th October 2014

Acquisition of Novartis Influenza Vaccines Business. 27 th October 2014 1 Acquisition of Novartis Influenza Vaccines Business 27 th October 2014 2 Legal Notice Forward looking statements The materials in this presentation speak only as of the date of these materials, and include

More information

14414/15 AF/evt 1 DG G 3 C

14414/15 AF/evt 1 DG G 3 C Council of the European Union Brussels, 25 November 2015 (OR. en) 14414/15 RECH 282 COMPET 531 SOC 684 NOTE From: Permanent Representatives Committee (Part 1) To: Council No. prev. doc.: 13902/15 RECH

More information

BSc (Hons) Medical Physiology and Diagnostics

BSc (Hons) Medical Physiology and Diagnostics BSc (Hons) Medical Physiology and Diagnostics Wolverhampton School of Sciences Ucas code: B122 Location Study mode Duration Start date Wolverhampton City Campus Full-time 3 year(s) 23/09/2019 Wolverhampton

More information

Slide 1. Jefferies 2014 Global Healthcare Conference 5-June Karsten Munk Knudsen CVP of Finance & IT at NNI

Slide 1. Jefferies 2014 Global Healthcare Conference 5-June Karsten Munk Knudsen CVP of Finance & IT at NNI Slide 1 Jefferies 2014 Global Healthcare Conference 5-June-2014 Karsten Munk Knudsen CVP of Finance & IT at NNI Slide 2 Agenda Highlights and key events Sales update R&D update Financials and outlook Slide

More information

Financial, social and environmental performance. Our focus is our strength

Financial, social and environmental performance. Our focus is our strength Financial, social and environmental performance Our focus is our strength Performance highlights 2008 2008 2007 Change Financial performance Sales total DKK million 45,553 41,831 9% Diabetes care DKK million

More information

PSYCHIATRY. THE POWER OFx. Experts. Experience. Execution. A Deeper Dive into Psychiatry. Scientifically-Driven Clinical Development

PSYCHIATRY. THE POWER OFx. Experts. Experience. Execution. A Deeper Dive into Psychiatry. Scientifically-Driven Clinical Development THE POWER OFx Experts. Experience. Execution. A Deeper Dive into Psychiatry Incidences of mental disorders such as depression, bipolar, anxiety disorders, and schizophrenia continue to grow around the

More information

at a glance

at a glance at a glance WWW.IVC.GROUP OVER 1,000 CLINICS AND HOSPITALS ACROSS EIGHT COUNTRIES AND COUNTING... It s been an incredible journey. When we founded the group in 2011, we started with just 20 practices.

More information

SUGAR, OBESITY AND DIABETES THE OTHER GLOBAL FOOD CRISIS

SUGAR, OBESITY AND DIABETES THE OTHER GLOBAL FOOD CRISIS Health & Life Sciences SUGAR, OBESITY AND DIABETES THE OTHER GLOBAL FOOD CRISIS A CROSS-SECTOR APPROACH TO DIET-RELATED CHRONIC DISEASE A breakfast discussion as part of Oliver Wyman s participation in

More information

First and foremost we have the world s largest privately funded biomedical research group investing about $8 billion in 2008.

First and foremost we have the world s largest privately funded biomedical research group investing about $8 billion in 2008. Rich Bagger s Talking Points for ECOSOC (Audience acknowledgement) Was asked to tackle the question: What are innovative ways that corporations can deploy their core competencies and strengths in the fight

More information

ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE

ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE CATALYSTS DRIVING SUCCESSFUL DECISIONS IN LIFE SCIENCES ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE AT KANTAR HEALTH, ONCOLOGY

More information